Yayınlar & Eserler

Yayın Ağı
Makaleler 31
Tümü (31)
SCI-E, SSCI, AHCI (21)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (1)
Scopus (31)
TRDizin (11)

1. TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD)

YILMAZ Y., Adali G., Ergenc I., Kaya E., TURAN GÖKÇE D., KEKLİKKIRAN Ç., et al.
Hepatology Forum , cilt.7, sa.3, ss.177-214, 2026 (Scopus) Creative Commons License

2. Familial Low-Phospholipid-Associated Cholelithiasis Syndrome Presenting with Recurrent Intrahepatic Stones After Cholecystectomy with a Heterozygous ABCB4 Variant

ADALI G., Kose M., Dertsiz B., Eser M., Kirbas I., Parlak E.
Turkish Journal of Gastroenterology , cilt.37, sa.8, ss.918-922, 2026 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

3. Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the turkish population: A multicenter study

Moral K., Harputluoğlu M., Özkumur G. F., Gavcar D., Erbay E., EREN F., et al.
Liver Transplantation , cilt.Publish Ahead of Print, 2026 (SCI-Expanded, Scopus)

4. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia

Takeuchi Y., Tateishi R., Obi S., Otsuka M., Mochizuki H., Jazag A., et al.
Hepatology International , cilt.20, sa.2, ss.373-383, 2026 (SCI-Expanded, Scopus)

5. Complete Immunosuppression Withdrawal After Liver Transplantation: An International Multicenter Study

Angelico R., Sensi B., Tisone G., Feng S., Roll G. R., Herrero I., et al.
Clinical Gastroenterology and Hepatology , 2026 (SCI-Expanded, Scopus) Creative Commons License

6. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis

ADALI G., Acar S., Harputluoğlu M., YILMAZ T. U., KARAKAYALI H., Istemihan Z., et al.
Clinical Transplantation , cilt.40, sa.1, 2026 (SCI-Expanded, Scopus)

7. Splenic Artery Aneurysm Following Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Rare Complication Presenting with Delayed Massive Gastrointestinal Bleeding

Aykut H., Ordu B., Dertsiz B., Saruhan M. A., ADALI G.
Turkish Journal of Gastroenterology , cilt.37, sa.2, ss.276-278, 2026 (SCI-Expanded, Scopus, TRDizin)

8. Non-invasive tests fail to ensure therapeutic precision for resmetirom in MASLD

ADALI G., AKDOĞAN R. A.
Hepatology Forum , cilt.6, sa.3, ss.89-90, 2025 (Scopus, TRDizin)

9. Virologic Response at 12 Months Predicts Lower Hepatocellular Carcinoma Risk in Genotype D Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues

Ozturk O., GÜZELBULUT F., Ozdil K., Aykut H., ADALI G.
Journal of Clinical Medicine , cilt.14, sa.8, 2025 (SCI-Expanded, Scopus) Creative Commons License

10. Leukocytoclastic vasculitis as a rare adverse effect of ustekinumab in a patient with Crohn's disease

Aykut H., Ordu B., Dertsiz B., ADALI G., Yalçın Ö.
Journal of gastrointestinal and liver diseases : JGLD , cilt.34, sa.1, ss.137-138, 2025 (SCI-Expanded, Scopus)

11. Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia

Choudhury A., Kulkarni A. V., Arora V., Soin A., Dokmeci A. K., Chowdhury A., et al.
Hepatology International , cilt.19, sa.1, ss.1-69, 2025 (SCI-Expanded, Scopus)

12. Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma

ADALI G., Aykut H., Bilgic N. M., YILMAZ Y.
Heliyon , cilt.10, sa.18, 2024 (SCI-Expanded, Scopus)

13. Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices

Choudhury A., ADALI G., Kaewdech A., Giri S., Kumar R.
Journal of Clinical and Experimental Hepatology , cilt.14, sa.3, 2024 (ESCI, Scopus)

14. Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study

ADALI G., Mutlu Bilgic N., Kalaman A. E., Ozturk O., Ozdil K.
Hepatology Forum , cilt.4, sa.3, ss.129-134, 2023 (Scopus, TRDizin)

15. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

YILMAZ Y., Zeybel M., ADALI G., COŞAR A. M., Sertesen E., GÖKCAN H., et al.
Hepatology Forum , cilt.4, ss.1-32, 2023 (Scopus, TRDizin)

16. Portal vein thrombosis risk factors in liver transplant candidates

Cagatay A., ADALI G., Sayar S., Agackiran A., KULALI F., Kahraman R., et al.
Hepatology Forum , cilt.3, sa.3, ss.88-92, 2022 (Scopus, TRDizin)

17. Characteristics of patients with hepatocellular carcinoma: A multicenter study

GÜZELBULUT F., KARAOĞULLARINDAN Ü., Akkiz H., Altintas E., DEMİRTAŞ C. Ö., Bahadir O., et al.
Hepatology Forum , cilt.3, sa.3, ss.71-76, 2022 (Scopus, TRDizin)

18. The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease

YORULMAZ E., ADALI G., Yorulmaz H., Taşan G., Gürses S., Ayaş M. R., et al.
Middle East Journal of Digestive Diseases , cilt.14, sa.3, ss.294-303, 2022 (Scopus) Creative Commons License

19. Outcomes of right lobe donors with BMI≥30 for living donor liver transplantation

Andacoglu O., Tokat Y., Malamutmann E., ADALI G., Emre A., Oezcelik A.
Clinical Transplantation , cilt.36, sa.7, 2022 (SCI-Expanded, Scopus)

20. Global multi-stakeholder endorsement of the MAFLD definition

Méndez-Sánchez N., Bugianesi E., Gish R. G., Lammert F., Tilg H., Nguyen M. H., et al.
The Lancet Gastroenterology and Hepatology , cilt.7, sa.5, ss.388-390, 2022 (SCI-Expanded, Scopus)

21. A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

Erdem L., Akbal E., Koçak E., Tucer D., Üçbilek E., Uyanıkoğlu A., et al.
Turkish Journal of Gastroenterology , cilt.33, sa.4, ss.286-293, 2022 (SCI-Expanded, Scopus, TRDizin)

22. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination

Moon A. M., Webb G. J., García-Juárez I., Kulkarni A. V., ADALI G., Wong D. K., et al.
Hepatology Communications , cilt.6, sa.4, ss.889-897, 2022 (SCI-Expanded, Scopus)

23. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment

Gokcen P., GÜZELBULUT F., ADALI G., Salturk A. G. D., Ozturk O., Bahadir O., et al.
World Journal of Gastroenterology , cilt.28, sa.6, ss.665-674, 2022 (SCI-Expanded, Scopus)

24. A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice

Gokcen P., Ozturk O., ADALI G., Tosun I., DOĞAN H. O., KARA H., et al.
Advances in Clinical and Experimental Medicine , cilt.30, sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License

25. Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation

Akarsu M., ÖNEM S., Turan I., ADALI G., Akdogan M., Akyildiz M., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.9, ss.712-719, 2021 (SCI-Expanded, Scopus, TRDizin)

26. Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease

Sayar S., Aykut H., Kaya Ö., Kürbüz K., Ak Ç., Gökçen P., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.7, ss.600-607, 2021 (SCI-Expanded, Scopus, TRDizin)

27. Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy

GÜZELBULUT F., Gökçen P., Can G., ADALI G., Değirmenci Saltürk A. G., Bahadır Ö., et al.
Journal of Viral Hepatitis , cilt.28, sa.5, ss.826-836, 2021 (SCI-Expanded, Scopus)

28. The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study

YILMAZ Y., Yilmaz N., Ates F., Karakaya F., GÖKCAN H., Kaya E., et al.
Hepatology Forum , cilt.2, sa.2, ss.37-42, 2021 (Scopus)

29. Comparison of the efficacy of entecavir and tenofovir in reducing hepatocellular carcinoma risk in chronic hepatitis b patients: A real-life study in turkey

GÜZELBULUT F., Gokcen P., Can G., ADALI G., Salturk A. G. D., Aslan E., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.4, ss.412-421, 2021 (SCI-Expanded, Scopus, TRDizin)

30. High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis

Ergenc I., Gokcen P., ADALI G., KANİ H. T., DEMİRTAŞ C. Ö., Gunduz F., et al.
Hepatology Forum , cilt.2, sa.1, ss.20-25, 2021 (Scopus)

31. High frequency of gastric cancer precursor lesions in patients with gastric xanthelasma: A prospective case-control study

Sayar S., Ayranci G., Kürbüz K., Ak Ç., Tarikçi Kiliç E., Kahraman R., et al.
European Journal of Gastroenterology and Hepatology , cilt.32, sa.9, ss.1130-1134, 2020 (SCI-Expanded, Scopus)
Metrikler

Yayın

31

Yayın (WoS)

30

Yayın (Scopus)

31

H-İndeks (WoS)

9

Atıf (Scopus)

564

H-İndeks (Scopus)

10

Atıf (TrDizin)

23

H-İndeks (TrDizin)

3

Atıf (Diğer Toplam)

23

Proje

1

Tez Danışmanlığı

5

Açık Erişim

9